Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio

Public research footprint of Cincinnati Children's Hospital Medical Center, compiled from the ClinicalTrials.gov public registry.

1,689

Registered studies

505

Active

288

Recruiting now

984

Completed

164

Stopped or withdrawn

Most-studied conditions

Botryoid-Type Embryonal Rhabdomyosarcoma · Advanced Malignant Solid Neoplasm · Spindle Cell Rhabdomyosarcoma · Recurrent Malignant Uterine Corpus Neoplasm

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT04616560 — Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory… (Recruiting)
NCT05691478 — A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Cincinnati Children's Hospital Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.